SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-087996
Filing Date
2023-03-31
Accepted
2023-03-31 16:02:01
Documents
10
Period of Report
2023-05-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A d423224dpre14a.htm PRE 14A 459747
2 GRAPHIC g423224dsp57.jpg GRAPHIC 1026
3 GRAPHIC g423224dsp57a.jpg GRAPHIC 928
4 GRAPHIC g423224dsp57b.jpg GRAPHIC 1340
5 GRAPHIC g423224dsp57c.jpg GRAPHIC 1192
6 GRAPHIC g423224dsp57f.jpg GRAPHIC 1558
7 GRAPHIC g423224dsp57g.jpg GRAPHIC 1094
8 GRAPHIC g423224dsp58.jpg GRAPHIC 1056
9 GRAPHIC g423224g13n02.jpg GRAPHIC 80356
10 GRAPHIC g423224g13n57.jpg GRAPHIC 51228
  Complete submission text file 0001193125-23-087996.txt   654655
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38692 | Film No.: 23787408
SIC: 2834 Pharmaceutical Preparations